New postmortem diagnostic biomarker for myocardial infarction: ischemia modified albumin

References

• Refaat MM, Hotait M, London B. Genetics of sudden cardiac death. Curr Cardiol Rep. 2015;17:7–606.
   PubMed Web of Science ®Google Scholar
• Aggarwal K, Seth S, Dahiya K, Aggarwal H, Aggarwal MK. Ischemia modified albumin in patients of cardiac and noncardiac chest pain. Biomed Res. 2001;23:61–65.
   Google Scholar
• Toker A, Aribas A, Yerlikaya FH, Tasyurek E, Akbuga A. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clinical Lab Analy. 2013;27:99–104.10.1002/jcla.21569
   PubMed Web of Science ®Google Scholar
• Ghormade PS, Kumar NB, Tingne CV, Keoliya AN. Distribution & diagnostic efficacy of cardiac markers CKMB & LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease. J Forensic Leg Med. 2014;28:42–46.10.1016/j.jflm.2014.09.011
   PubMed Web of Science ®Google Scholar
• Hu BJ, Chen YC, Zhu JZ. Immunohistochemical study of fibronectin for post-mortem diagnosis of early myocardial infarction. Forensic Sci Int. 1996;78:209–217.10.1016/0379-0738(96)01891-9
   PubMed Web of Science ®Google Scholar
• Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Bessho Y, et al. Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. Leg Med. 2007;9(5):241–250.10.1016/j.legalmed.2007.01.010
   PubMedGoogle Scholar
• Bar-Or D, Lau E, Rao N, Bampos N, Winkler JV, Curtis CG. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia. Ann Energ Med. 1999;34:S56.10.1016/S0196-0644(99)80299-6
   Google Scholar
• Morrow DA, De Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem. 2003;49:537–539.10.1373/49.4.537
   PubMed Web of Science ®Google Scholar
• Ma S, Jin Y, Hu W, Bai F, Xu W, Yu W. Evaluation of ischemia-modified albumin and Creactive protein in type 2 diabetics with and without ketosis. Biomark Insights. 2012;7:19–26.
   PubMedGoogle Scholar
• Kösem A, Haklıgör A, Yücel D. Effects of calcium (II), magnesium (II), copper (II) and iron (II) ions on ischemia modified albumin. Turk J Biochem. 2008;33:31–34.
   Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NK, Curtis CG. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta. 2008;387:1–2.
   PubMed Web of Science ®Google Scholar
• Vijaya D, Gayathri B. Role of ischemia modified albumin in the early diagnosis of acute myocardial infarction. Innovative J Med Health Sci. 2014;4(1):353–358.
   Google Scholar
• Piehler AP, Urdal P. Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia modified albumin: a pilot study. Clin Chem. 2009;55(8):31–34.
   Web of Science ®Google Scholar
• Chawla SR, Goyal N, Calton R, Goyal S. Ischemia modified albumin: a novel marker for acute coronary syndrome. Indian J Clin Biochem. 2006;21(1):77–82.10.1007/BF02913070
   PubMedGoogle Scholar
• Jiang T, Tao Y, Huang C, Liu X, Qiu X, Zhang H, Cui T, Luo Y. Ruling out myocardial ischemia using ischemia-modified albumin: a systemic review and meta-analysis. Exp Clin Cardiol. 2014;20:7–1270.
   Google Scholar
• Christenson RH, Duh SH, Sanhai WR, Wu A, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an albumin cobalt binding test for the assessment of acute coronary. Clin Chem. 2011;47(3):464–470.
   Google Scholar
• Hazini A, Cemek M, Işıldak I, Alpdağtaş S, Önül A, Şenel Ü, Kocaman T, Dur A, Iraz M, Uyarel H. Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction. Adv Interv Cardiol. 2015;4(42):1–6.
   Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia–a preliminary report. J Emerg Med. 2000;19:311–315.10.1016/S0736-4679(00)00255-9
   PubMed Web of Science ®Google Scholar
• Madea B, Musshoff F. Postmortem biochemistry. Forensic Sci Int. 2007;165:165–171.10.1016/j.forsciint.2006.05.023
   PubMed Web of Science ®Google Scholar
• Van BE, Dallongeville J, Vicaut E, Degrandsart A, Baulac C, Montalescot G. Ischemia modified albumin levels predict longterm outcome in patients with acute myocardial infarction, The French Nationwide OPERA study. Am Heart J. 2010;159(49):570–576.
   PubMedGoogle Scholar
• Roy D, Quiles J, Sinha M. Effect of direct-current cardioversion on ischemia-modified albümin levels in patients with atrial fibrillation. Am J Cardiol. 2004;93:366–368.10.1016/j.amjcard.2003.10.023
   PubMed Web of Science ®Google Scholar
• Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J. 2004;21:29–34.10.1136/emj.2003.006007
   PubMed Web of Science ®Google Scholar
• Ali OS, Abdelgawad HM, Mohammed MS, El-Awady RR. Ischemic heart diseases in Egypt: role of xanthine oxidase system and ischemia-modified albümin. Heart Vessels. 2014;29:629–637.10.1007/s00380-013-0413-3
   PubMed Web of Science ®Google Scholar
• Dawie J, Chawla R, Worku Y, Azazh A. Diagnosis of ischemic heart disease using CK-MB, troponin-I and ischemia modified albumin. Ethiop Med J. 2011;49(1):25–33.
   PubMedGoogle Scholar
• Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653.10.1161/CIRCULATIONAHA.107.187397
   PubMed Web of Science ®Google Scholar
• Wang Q, Michiue T, Ishikawa T, Zhu BL, Maeda H. Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases. Legal Medicine. 2011;13(5):226–232.10.1016/j.legalmed.2011.05.002
   PubMed Web of Science ®Google Scholar
• Pérez-Cárceles A, Noguera J, Jiménez JL, Martínez P, Luna A, Osuna E. Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart disease. MD Forensic Sci Int. 2004;142(1):1–7.10.1016/j.forsciint.2004.02.007
   PubMed Web of Science ®Google Scholar
• Luna A, Villanueva E, Castellano MA, Jimenez G. The determination of CK, LDH and its isoenzymes in pericardial fluid and its application to the post-mortem diagnosis of myocardial infarction. Forensic Sci Int. 1982;19:85–91.10.1016/0379-0738(82)90154-2
   PubMed Web of Science ®Google Scholar
• Maeda H, Ishikawa T, Michiue T. Forensic biochemistry for functional investigation of death: concept and practical application. Leg Med (Tokyo). 2011;13:55–67.10.1016/j.legalmed.2010.12.005
   PubMed Web of Science ®Google Scholar
• Živković V, Nikolić S. Unusual changing localization of acute myocardial ischemia in a case of an aortic dissection. Aust J Forensic Sci. 2015;48:317–322.
   Web of Science ®Google Scholar